1. Home
  2. MNTS vs RNXT Comparison

MNTS vs RNXT Comparison

Compare MNTS & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Momentus Inc.

MNTS

Momentus Inc.

HOLD

Current Price

$2.15

Market Cap

74.2M

Sector

Industrials

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

SELL

Current Price

$1.27

Market Cap

79.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MNTS
RNXT
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.2M
79.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
MNTS
RNXT
Price
$2.15
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $7.13
AVG Volume (30 Days)
★ 555.6K
459.8K
Earning Date
11-19-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.00
EPS
N/A
★ N/A
Revenue
$1,110,000.00
★ $1,123,000.00
Revenue This Year
$660.36
$244.84
Revenue Next Year
$42.18
$195.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2511.63
52 Week Low
$0.44
$0.70
52 Week High
$22.20
$2.59

Technical Indicators

Market Signals
Indicator
MNTS
RNXT
Relative Strength Index (RSI) 19.25 43.24
Support Level N/A $0.83
Resistance Level $4.44 $1.30
Average True Range (ATR) 0.22 0.09
MACD -0.08 0.00
Stochastic Oscillator 5.89 38.54

Price Performance

Historical Comparison
MNTS
RNXT

About MNTS Momentus Inc.

Momentus Inc is a U.S.-based commercial space company engaged in providing satellites, satellite buses, and in-space infrastructure services. The company offers space transportation, hosted payload, and in-orbit servicing solutions, including last-mile satellite delivery, refueling, inspection, maintenance, and debris removal. It also develops satellite technologies such as solar arrays and propulsion systems, and provides production and operation of small satellites for government, defense, and commercial customers.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: